SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,409,000 | +25.3% | 362,327 | +63.1% | 0.01% | +33.3% |
| Q4 2015 | $3,520,000 | -26.2% | 222,133 | -28.6% | 0.01% | -33.3% |
| Q3 2015 | $4,771,000 | -54.2% | 311,251 | -27.3% | 0.01% | -47.1% |
| Q2 2015 | $10,408,000 | +16.6% | 428,131 | +11.6% | 0.02% | +6.2% |
| Q1 2015 | $8,923,000 | +7.5% | 383,795 | +15.9% | 0.02% | +6.7% |
| Q4 2014 | $8,301,000 | +39.0% | 331,024 | +72.3% | 0.02% | +36.4% |
| Q3 2014 | $5,974,000 | +142.4% | 192,090 | +101.6% | 0.01% | +175.0% |
| Q2 2014 | $2,465,000 | +92.1% | 95,273 | +52.8% | 0.00% | +100.0% |
| Q1 2014 | $1,283,000 | +18.7% | 62,359 | +9.1% | 0.00% | 0.0% |
| Q4 2013 | $1,081,000 | +4.1% | 57,164 | +12.4% | 0.00% | 0.0% |
| Q3 2013 | $1,038,000 | +29.3% | 50,857 | +32.8% | 0.00% | +100.0% |
| Q2 2013 | $803,000 | – | 38,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,495,416 | $97,301,000 | 26.57% |
| Stonepine Capital Management, LLC | 356,307 | $5,337,000 | 5.47% |
| Penn Capital Management Company, LLC | 1,841,035 | $27,673,000 | 1.57% |
| SECTORAL ASSET MANAGEMENT INC | 1,008,265 | $15,104,000 | 1.56% |
| Tamarack Advisers, LP | 259,336 | $3,885,000 | 1.49% |
| THB ASSET MANAGEMENT | 632,499 | $9,474,000 | 1.23% |
| JW Asset Management, LLC | 101,630 | $1,522,000 | 1.21% |
| Healthcare Value Capital, LLC | 50,000 | $749,000 | 0.91% |
| Kerrisdale Advisers, LLC | 190,372 | $2,851,000 | 0.77% |
| Healthcare Value Capital, LLC | 35,000 | $524,000 | 0.64% |